Thus, SPI1 knockdown synergizes with erastin to promote lipid peroxidation and ferroptosis, suggesting that targeting SPI1 may represent a promising therapeutic strategy for renal cell carcinoma. The gene discussed is SPI1; the disease is hereditary clear cell renal cell carcinoma.